 Issue 014 |
|
Unlocking the intradermal route
BD
The Mantoux technique, the traditional method of delivering therapies by injection through the skin, is difficult to use and prone to mis-injection. BD Soluvia™ is an innovative microinjection system that allows simple and reliable intradermal injection. more... |
| |
|
| |
Focus on quality and value
Forteq
The demands on drug delivery and self-diagnostics devices are growing, but manufacturers of high-precision components are offering device companies better quality and value. This is the message major pharma wants to hear. more... |
| |
|
| |
The aerosol challenge
DuPont
Patient safety remains the number one priority when it comes to drug delivery and that includes the production of a non-CFC aerosol. DuPont has produced a number of CFC alternatives in the search for the perfect pharmaceutical propellant. more... |
|
 Issue 013 |
|
Smart solution to challenging compounds
SOLIQS
More drug makers are turning to melt extrusion technology as a low risk way of formulating drug molecules with challenging profiles. A unique alternative has been developed that will add value to the formulation of both new molecular entities and established products. more... |
| |
|
| |
Value for brands and patients
Meldex International
Pharmaceutical products need to be immediately effective: for consumers and for manufacturers requiring brand protection. Polymer technology provides a simple anti-counterfeiting system that has instant absorption capabilities. more... |
| |
|
| |
New life for drug compounds
Eurand
Drug solubility is an important factor influencing the rate and extent of drug absorption, therefore determining the overall bioavailability. Bioavailability technologies offer solutions that overcome the challenges of poor drug solubility. more... |
| |
|
| |
Oral controlled release technologies
Penwest Pharmaceuticals
In an era where formulation challenges are increasingly common, established, flexible, oral controlled release technologies are important tools for creating approvable, innovative products. more... |
|
 Issue 012 |
|
ODT: simple and effective
Eurand Pharmaceuticals
The efficacy of any treatment depends on patients’ compliance with their regimen. Reducing the number of doses and offering medication in a form that is easy to take can positively affect patient behaviour. The next generation of orally disintegrating tablets combines these benefits in one, simple product. more... |
|
 Issue 011 |
|
|
|
 Issue 010 |
|
Patient-friendly ODTs
Eurand
Many tablets are hard to swallow: they are bitter tasting, disintegrate
slowly and do not take effect for about an hour after administration. One
company has worked to successfully overcome these challenges. more... |
| |
|
| |
Streamlining ODT technology
Developing orally disintegrating tablets can be expensive due to their complex dosage forms. Two platforms are available that aim to improve the manufacturing process. more... |
| |
|
| |
Delivering excellent products and services
Cardinal Health
Cardinal Health is a global leader in development, drug delivery technologies, contract manufacturing, packaging and product commercialisation services, serving the worldwide pharmaceutical and biotechnology industries. more... |
| |
|
| |
Developing greener and more effective inhalers
DuPont
The challenge of developing more environmentally friendly inhalers has provided the perfect opportunity to improve current formulations of pharmaceutical aerosols. more... |
|
 Issue 009 |
|
Intelligent nasal drug delivery
Kurve Technology, Inc
Current drug delivery systems track and validate prescription drugs from manufacturer to retailer, thereby curtailing fraud. However, the industry also requires systems that validate the product at patient level to avoid drug misuse. more... |
| |
|
|
| |
|
Engineering intelligence for high-volume production
Mikron Plastics Technology
Producing small complex plastic components in high volumes can be a difficult process. Luckily, expert knowledge is readily available. more... |
|
 Issue 008 |
|
Pulmonary delivery – the next wave
Nektar Therapeutics
The outlook is increasingly promising for products that deliver medicines to and through the respiratory system. more... |
| |
|
| |
Layering nanocapsules and microcapsules
Capsulution NanoScience AG
A large amount of pharmaceutical R&D resources are being spent on enhancing the delivery properties of existing and new drugs. Over the last years, an extended research community has been built around the use of innovative formulation processes. One of these new formulation processes, which have seen promising advances is called LBL-Technology®. more... |
| |
|
| |
Needle-free injectors evolve
Crossjet SA
There is now much more interest in needle-free technologies, as more sophisticated solutions reach the market. Manufacturers hope that customers will take a long-term view of costs, as there is value behind the higher purchase price of needle-free injectors. more... |
| |
|
| |
Measured in numbers
SI Associates Ltd
'I often say that when you can measure what you are speaking about, and express it in numbers, you know something about it.' more... |
| |
|
| |
Related articles from this issue |
| |
|
| |
 Global Alliance Development
Alliances are becoming more common in the
pharmaceuticals industry. The Global Discovery Alliances team at AstraZeneca reveal the merits such ventures have in contributing to the success of a company’s business strategy. |
|
 Issue 007 |
|
Alginate, chitosan and hyaluronan in drug delivery
FMC BioPolymer
By Dr Michael Dornish, VP research and development, and Dr Are Kristiansen, commercial development manager, at FMC BioPolymer...
click here for more |
